Literature DB >> 25906242

Teriparatide fracture effectiveness in the real world.

J H Krege1, R T Burge, F Marin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25906242     DOI： 10.1007/s00198-015-3140-z

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  6 in total

1.  The impact of teriparatide adherence and persistence on fracture outcomes.

Authors:  S Yu; R T Burge; S A Foster; S Gelwicks; E S Meadows
Journal:  Osteoporos Int       Date:  2011-12-08       Impact factor: 4.507

2.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

Authors:  R M Neer; C D Arnaud; J R Zanchetta; R Prince; G A Gaich; J Y Reginster; A B Hodsman; E F Eriksen; S Ish-Shalom; H K Genant; O Wang; B H Mitlak
Journal:  N Engl J Med       Date:  2001-05-10       Impact factor: 91.245

3.  Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis.

Authors:  R Lindsay; P Miller; G Pohl; E V Glass; P Chen; J H Krege
Journal:  Osteoporos Int       Date:  2008-10-16       Impact factor: 4.507

4.  Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS).

Authors:  A Fahrleitner-Pammer; B L Langdahl; F Marin; F Jakob; D Karras; A Barrett; Ö Ljunggren; J B Walsh; G Rajzbaum; C Barker; W F Lems
Journal:  Osteoporos Int       Date:  2010-11-27       Impact factor: 4.507

5.  Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis.

Authors:  M M Bonafede; N Shi; A G Bower; R L Barron; A Grauer; D B Chandler
Journal:  Osteoporos Int       Date:  2015-01-08       Impact factor: 4.507

6.  The Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) study: 2-year nonvertebral fragility fracture results.

Authors:  S Silverman; P Miller; A Sebba; M Weitz; X Wan; J Alam; D Masica; K A Taylor; V A Ruff; K Krohn
Journal:  Osteoporos Int       Date:  2013-02-12       Impact factor: 4.507
  6 in total
  3 in total

Review 1.  Teriparatide for osteoporosis: importance of the full course.

Authors:  R Lindsay; J H Krege; F Marin; L Jin; J J Stepan
Journal:  Osteoporos Int       Date:  2016-02-22       Impact factor: 4.507

2.  Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.

Authors:  R T Burge; D P Disch; S Gelwicks; X Zhang; J H Krege
Journal:  Osteoporos Int       Date:  2016-12-27       Impact factor: 4.507

3.  Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS).

Authors:  Bente L Langdahl; Östen Ljunggren; Claude-Laurent Benhamou; Fernando Marin; George Kapetanos; Tomaz Kocjan; Eric Lespessailles; Nicola Napoli; Tatjana Nikolic; Helmut Petto; Thomas Moll; Erik Lindh
Journal:  Calcif Tissue Int       Date:  2016-04-30       Impact factor: 4.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.